Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19

NCT04403243 is registered in ClinicalTrials.gov with Lomonosov Moscow State University Medical Research and Educational Center as lead sponsor.

NCT NCT04403243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04403243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19
Lead sponsor
Lomonosov Moscow State University Medical Research and Educational Center
Phase
Phase 2
Overall status
Completed
Start date
May 8, 2020
Completion date
August 23, 2020
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19